Vistagen Therapeutics Inc (NASDAQ:VTGN) currently has a daily average trading volume of 135.64K but it saw 413987 shares traded in last market. With a market cap of 59.45M USD, the company’s current market price of $2.06 came falling about -13.45 while comparing to the previous closing price of $2.38. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.21 and as low as $1.90. In the recent trading on the day, stock has struck highest price mark of $2.05 while lowest mark touched by it was $2.3533.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Jefferies which upgraded the stock as “Buy” in its note to investors issued on December 07, 2023, recommending a price target of $15 for it. Maxim Group upgraded its recommendation for the stock as a “Buy” from “Hold” on August 07, 2023 while assigning a price target of $30.
Over the week, VTGN’s stock price is moving -12.71% down while it is -19.06% when we observe its performance for the past one month. Year-to-date it is -30.17% down and over the past year, the stock is showing a downside performance of -41.48%.
Currently, Vistagen Therapeutics Inc’s total number of outstanding shares is 28.32M. Company’s return on investment (ROI) stands at -57.53% and return on equity (ROE) at -46.28%. Stock’s beta reads 0.69. Stock has a price to book (P/B) ratio of 0.72 while price to sale or P/S ratio amounts to 84.93. Its return on asset (ROA) is -42.35% on average.
